LPL Financial
HQL

LPL Financial’s abrdn Life Sciences Investors HQL Stock Holding History

LPL Financial’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.79M Buy
478,802
+29,956
+7% +$501K ﹤0.01% 2218
2025
Q4 		$7.53M Buy
448,846
+74,787
+20% +$1.26M ﹤0.01% 2183
2025
Q3 		$5.8M Buy
374,059
+29,700
+9% +$407K ﹤0.01% 2336
2025
Q2 		$4.41M Buy
344,359
+15,957
+5% +$197K ﹤0.01% 2419
2025
Q1 		$4.17M Buy
328,402
+41,307
+14% +$559K ﹤0.01% 2304
2024
Q4 		$3.77M Buy
287,095
+129,313
+82% +$1.87M ﹤0.01% 2306
2024
Q3 		$2.38M Buy
157,782
+2,016
+1% +$30.5K ﹤0.01% 2561
2024
Q2 		$2.21M Buy
155,766
+4,774
+3% +$64.6K ﹤0.01% 2515
2024
Q1 		$2.06M Sell
150,992
-1,730
-1% -$23.9K ﹤0.01% 2519
2023
Q4 		$2.06M Sell
152,722
-4,969
-3% -$61.1K ﹤0.01% 2379
2023
Q3 		$1.97M Sell
157,691
-2,862
-2% -$37.6K ﹤0.01% 2292
2023
Q2 		$2.17M Sell
160,553
-7,058
-4% -$97.4K ﹤0.01% 2171
2023
Q1 		$2.33M Buy
167,611
+5,723
+4% +$81.8K ﹤0.01% 2014
2022
Q4 		$2.3M Sell
161,888
-35,029
-18% -$507K ﹤0.01% 1970
2022
Q3 		$2.69M Buy
196,917
+2,834
+1% +$42.4K ﹤0.01% 1776
2022
Q2 		$2.76M Sell
194,083
-1,074
-0.6% -$16.2K ﹤0.01% 1775
2022
Q1 		$3.23M Sell
195,157
-12,553
-6% -$216K ﹤0.01% 1706
2021
Q4 		$3.99M Buy
207,710
+60,486
+41% +$1.22M ﹤0.01% 1601
2021
Q3 		$3.06M Buy
147,224
+23,731
+19% +$508K ﹤0.01% 1729
2021
Q2 		$2.65M Buy
123,493
+5,785
+5% +$117K ﹤0.01% 1762
2021
Q1 		$2.32M Buy
117,708
+13,411
+13% +$276K ﹤0.01% 1738
2020
Q4 		$2.06M Buy
104,297
+5,546
+6% +$103K ﹤0.01% 1655
2020
Q3 		$1.74M Buy
98,751
+6,751
+7% +$121K ﹤0.01% 1548
2020
Q2 		$1.65M Buy
92,000
+12,605
+16% +$216K ﹤0.01% 1472
2020
Q1 		$1.19M Buy
79,395
+8,364
+12% +$137K ﹤0.01% 1508
2019
Q4 		$1.24M Buy
71,031
+12,025
+20% +$197K ﹤0.01% 1684
2019
Q3 		$891K Buy
59,006
+3,849
+7% +$61.7K ﹤0.01% 1821
2019
Q2 		$929K Sell
55,157
-5,837
-10% -$96.1K ﹤0.01% 1776
2019
Q1 		$1.04M Sell
60,994
-1,397
-2% -$24.1K ﹤0.01% 1625
2018
Q4 		$943K Sell
62,391
-413
-0.7% -$7.27K ﹤0.01% 1577
2018
Q3 		$1.28M Buy
62,804
+2,480
+4% +$49.3K ﹤0.01% 1488
2018
Q2 		$1.13M Sell
60,324
-8,427
-12% -$159K ﹤0.01% 1539
2018
Q1 		$1.32M Sell
68,751
-41,183
-37% -$825K ﹤0.01% 1400
2017
Q4 		$2.16M Sell
109,934
-4,692
-4% -$94K 0.01% 1016
2017
Q3 		$2.46M Buy
114,626
+31,693
+38% +$673K 0.01% 879
2017
Q2 		$1.73M Sell
82,933
-38,593
-32% -$780K 0.01% 1025
2017
Q1 		$2.35M Buy
121,526
+18,542
+18% +$344K 0.02% 747
2016
Q4 		$1.78M Buy
102,984
+18,891
+22% +$332K 0.01% 870
2016
Q3 		$1.56M Buy
84,093
+7,860
+10% +$148K 0.01% 900
2016
Q2 		$1.36M Sell
76,233
-50,749
-40% -$937K 0.01% 974
2016
Q1 		$2.34M Sell
126,982
-5,749
-4% -$104K 0.01% 1105
2015
Q4 		$3.08M Buy
132,731
+65,941
+99% +$1.64M 0.01% 939
2015
Q3 		$1.62M Sell
66,790
-14,283
-18% -$400K 0.01% 948
2015
Q2 		$2.33M Sell
81,073
-57,396
-41% -$1.59M 0.01% 835
2015
Q1 		$3.77M Buy
138,469
+35,337
+34% +$964K 0.02% 632
2014
Q4 		$2.57M Buy
103,132
+48,582
+89% +$1.17M 0.01% 757
2014
Q3 		$1.19M Buy
54,550
+1,650
+3% +$35.8K 0.01% 1158
2014
Q2 		$1.1M Buy
52,900
+1,723
+3% +$36.2K 0.01% 1255
2014
Q1 		$1.11M Buy
51,177
+16,815
+49% +$374K 0.01% 1198
2013
Q4 		$702K Sell
34,362
-2,716
-7% -$52.7K ﹤0.01% 1495
2013
Q3 		$694K Buy
37,078
+4,745
+15% +$90.9K ﹤0.01% 1417
2013
Q2 		$578K Buy
+32,333
New +$584K ﹤0.01% 1462

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

LPL Financial's HQL Position: Q1 2026 in Review

LPL Financial increased its abrdn Life Sciences Investors (HQL) stake by 6.7% in Q1 2026, buying an estimated $501K and bringing the position to 478,802 shares worth $7.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2218.

LPL Financial first reported a position in HQL in Q2 2013 and has held it in 52 quarters since. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • LPL Financial held 478,802 shares of abrdn Life Sciences Investors worth $7.79M as of Q1 2026.
  • LPL Financial bought 29,956 abrdn Life Sciences Investors shares in Q1 2026, an estimated $501K.
  • abrdn Life Sciences Investors made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #2218 holding.
  • LPL Financial first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 52 quarters since.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.